Breast cancer patients including those with locally advanced (unresectable) or metastatic HER2-positive research hub

Phase 2a Study of ZW25 in Combination with Palbociclib Plus Fulvestrant

This study is looking at a new treatment for certain types of advanced breast cancer. It combines a new drug (ZW25) with existing medicines (palbociclib and fulvestrant) to see if it's safe and effective for patients whose cancer has spread or can't be removed by surgery.